KRAS and malignant colon neoplasm: As preclinical model system of human colon cancer, we used the established sensitive and cetuximab-resistant GEO cell lines (GEO and GEO-CR, respectively), proved to be a valuable tool for elucidating mechanisms of acquired cancer cell resistance since parental cells are very sensitive to cetuximab treatment despite the presence of a mutation in KRAS [15].